SGLT-2 inhibitor drugs are prescribed to improve the treatment of diabetes, chronic kidney disease or heart failure. The name of these drugs ends with ‘gliflozin’. These drugs are proven to reduce mortality in the majority of patients. Recent research has highlighted a very rare but important side effects which can occur with these drugs including Diabetic Ketoacidosis and Fourniers Gangrene. These are very rare but it can be dangerous if not identified. For more details please read this information leaflet
For more information on this topic please download this information leaflet
